ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,702Medicare Part D Prescriptions Filled, Including Refills

Rank: 474 out of 6969

$604K Total Retail Price of All Prescriptions

Rank: 395 out of 6969

455 Patients Receiving at Least One Drug in Part D
66%Patients 65 Years and Older
59% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

15% of this provider’s 455 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

37% of this provider’s 455 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,944 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
HYDROCODONE-ACETAMINOPHEN 930 444 S3 1 3
SIMVASTATIN 371 265 2 1
LISINOPRIL 367 285 3 2
OMEPRAZOLE 335 192 4 6
FUROSEMIDE 286 238 5 10
AMLODIPINE BESYLATE 246 150 6 4
LEVOTHYROXINE SODIUM 228 172 7 5
ZOLPIDEM TARTRATE 209 136 8 16
CYMBALTA 173 79 9 72
METFORMIN HCL 149 100 10 7
TAMSULOSIN HCL 140 99 11 23
POTASSIUM CHLORIDE 134 106 12 30
GABAPENTIN 121 64 13 17
MORPHINE SULFATE ER 118 40 S2 14 90
PROAIR HFA 101 32 15 33
METOPROLOL SUCCINATE 101 93 15 22
GLIMEPIRIDE 93 68 17 44
ATORVASTATIN CALCIUM 84 58 18 11
CRESTOR 80 56 19 39
PRAVASTATIN SODIUM 80 47 19 19
NEXIUM 79 49 21 52
ATENOLOL 78 67 22 9
TRAZODONE HCL 74 36 23 47
CITALOPRAM HBR 73 59 24 34
IBUPROFEN 71 38 25 29
QUETIAPINE FUMARATE 69 17 26 101
LANTUS 69 38 26 50
FLUOXETINE HCL 69 50 26 43
LANTUS SOLOSTAR 67 38 29 154
FENTANYL 67 20 S2 29 113
ADVAIR DISKUS 66 43 31 45
METOPROLOL TARTRATE 65 39 32 13
LYRICA 64 56 33 137
DIOVAN 64 47 33 26
WARFARIN SODIUM 64 42 33 20
PANTOPRAZOLE SODIUM 63 55 36 31
OXYCODONE HCL-ACETAMINOPHEN 60 0 S2 37 180
PAROXETINE HCL 59 40 38 65
METHADONE HCL 58 17 S2 39 121
HYDROCHLOROTHIAZIDE 58 53 39 8
GLIPIZIDE ER 58 57 39 199
TRAMADOL HCL 55 18 42 27
DIGOXIN 54 54 43 71
CARISOPRODOL 51 12 R 44 69
ESTRADIOL 51 35 R 44 124
ALENDRONATE SODIUM 51 40 44 14
FLUTICASONE PROPIONATE 51 17 44 24
SYNTHROID 50 16 48 94
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 21, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.